We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On August 9, 2010, the Food and Drug Administration ("FDA") published a notice announcing a public meeting to be held September 17, 2010, "to gather stakeholder input on the development of a generic drug user fee program."
HSE Management who engage agency workers to cover a short-term need, such as an upturn in hospital admissions, sickness, absence or maternity leave, should be aware of the potentially far-reaching consequences of the Temporary Agency Workers Directive (the “Directive”
